Colon cancers are increasing among younger Americans, so much so that experts advised in 2021 that colonoscopy screening begins at the age of 45, not 50 as had been previously recommended. Now, research shows the new guideline may have led to a tripling in the use of the gold-standard screen among folks ages 45 to...
Month: <span>October 2024</span>
Post
New imaging technique accurately detects aggressive kidney cancer
Representative imaging with [89Zr]Zr-girentuximab. Credit: The Lancet Oncology (2024). DOI: 10.1016/S1470-2045(24)00402-9 A new study led by investigators from the UCLA Health Jonsson Comprehensive Cancer Center has demonstrated a new, non-invasive imaging technique can accurately detect clear-cell renal cell carcinoma, the most common form of kidney cancer. The findings, published in The Lancet Oncology, could greatly reduce the number...
Post
Prostatic artery embolization offers lasting benefit for benign prostatic hyperplasia: Study
For men with benign prostatic hyperplasia (BPH), prostatic artery embolization (PAE) is safe and effective over 24 months of follow-up, according to a study published online Sept. 4 in Cardiovascular and Interventional Radiology. Marc R. Sapoval, M.D., Ph.D., from the Assistance Publique-Hôpitaux de Paris, and colleagues conducted an international trial of men with BPH with lower urinary tract symptoms (LUTS)...
Post
Influenza vaccine protects children from infection and hospitalization for the disease, Spanish study shows
An article published in Eurosurveillance has demonstrated that Spain’s influenza vaccination campaign for children aged 6–59 months during the 2023/24 season was effective in preventing acute respiratory infections (ARI) and hospitalization, as vaccination was recommended for this age group at the national level for the first time. In the context of Child Health Day 2024, this research emphasizes that...
Post
Common consumer product chemicals now tied to cardiac electrical changes
Common consumer product chemicals now tied to cardiac electrical changes Graphic summary of the effect of phenol exposure on ECG parameters in the Fernald Cohort. Effect size represents the change in the value of ECG parameters with a change in one unit of log transformed urinary phenol concentration. Red bars illustrate effects that have statistical...
Post
Here’s why B cells benefit from booster shots
Recall germinal centers formed in response to a secondary infection generate a second line of defense, rebuffing memory B cells in favor of training naive ones. Credit: Rockefeller University Certain infectious diseases, such as COVID or the flu, evolve constantly, shapeshifting just enough to outmaneuver our immune systems and reinfect us repeatedly. But subsequent reinfections...
Post
This season’s flu vaccine cuts risk of hospitalization by almost 35%, finds report
The Southern Hemisphere’s flu season is winding down, and new data shows this year’s flu shot was 34.5% effective in keeping folks there who got influenza from needing hospital care. Most (68.3%) of those sent to hospital had the A(H3N2) strain of flu, according to the report from the U.S. Centers for Disease Control and...
Post
Study demonstrates that mpox vaccine antibody responses wane within a year
Mpox Virus Particle Colorized transmission electron micrograph of an mpox virus particle (yellow and red) found within an infected VERO E6 cell (blue), cultured in the laboratory. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID/CC0 Public Domain A study led by researchers at Beth Israel Deaconess Medical Center...
Post
Scientists may have found the reason why people with schizophrenia hear voices
People with schizophrenia often “hear” voices and sounds even when there are none — up to 80% of people with the mental illness have auditory hallucinations. Scientists have theorized that this happens when a person with schizophrenia struggles to recognize inner speech as self-generated. But nobody had been able to fully explain the mechanisms behind this...
Post
Direct Brain A-Dopamine Infusion Promising for Parkinson’s Disease
PHILADELPHIA — Continuous intracerebroventricular administration of an anaerobic dopamine formulation (A-dopamine) appears safe in patients with Parkinson’s disease (PD) and may avoid complications associated with levodopa, results from a first in-human trial suggest. A-dopamine induced a dose-dependent improvement in motor symptoms in refractory patients with severe levodopa complications and had a “really great” safety profile, said study investigator...